This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX World Congress
28th -30th April 2025
Day Zero - CEO Forum Day (April 28)​Business Design Centre, London, UK

Mr Antony Mattessich
CEO at Amphista
Speaker

Profile

Antony is an experienced CEO with over 30 years’ experience in the life science industry. He has an impressive track record in progressing programs from discovery, through clinical development and commercial success, and strong capital markets experience.

Antony has held several senior executive positions where he was instrumental in developing medicines that translate innovative science into meaningful clinical outcomes for patients, with extensive experience in CNS, haemato-oncology, immunology, and metabolics. Most recently, he was President and CEO of Nasdaq-listed Ocular Therapeutix (OCUL), where he launched the company’s lead asset and brought its potential blockbuster in Wet Age-Related Macular Degeneration (wet-AMD) from pre-clinical development into active enrolment in Phase 3.

Prior to Ocular, Antony was Managing Director of Mundipharma and has held senior positions at Novartis and Bristol-Myers Squibb.

Antony holds a BA from the University of California at Berkeley and a Masters in International affairs from Columbia University.

Agenda Sessions

  • Cultivating Success: Building a Vibrant Transatlantic Biotech Culture

    16:20